In a prospective 1-year longitudinal study of a human population in the Brazilian Amazon Basin in which asymptomatic P. vivax patients had been previously, identified high levels of antibodies against the N-terminus of Pv-MSP1 were observed in individuals clinically protected from malaria. The gene discussed is ATAD1; the disease is malaria.